Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Simona Ciccarelli, Ilaria Stolfi & Giuseppe Caramia. (2013) Management strategies in the treatment of neonatal and pediatric gastroenteritis. Infection and Drug Resistance 6, pages 133-161.
Read now
Read now
Articles from other publishers (52)
Ahmet Yıldırım, Ahmet Özbilgin & Kor Yereli. (2023)
Antiprotozoal activity of auranofin on
Trypanosoma cruzi, Leishmania tropica
and
Toxoplasma gondii
: in vitro and ex vivo study
. Transactions of The Royal Society of Tropical Medicine and Hygiene.
Crossref
Crossref
Natasha Naval Aggarwal, S.M. Sindhoor, N. Raghavendra Naveen, Buduru Gowthami & Prajitha Biju. (2023) Drug Reprofiling: A Prospective Approach to Battle Chronic Ailments. Journal of Health and Allied Sciences NU.
Crossref
Crossref
Samah Hassan Yahia, Reda Lamei El gamal, Ghada Mahmoud Fathy, Asmaa Mohammed Farouk Al-Ghandour, Nadia El-Akabawy, Basma Hosny Abdel-Hameed & Enas Saed Elbahaie. (2023) The potential therapeutic effect of Nigella sativa and Zingiber officinale extracts versus Nitazoxanide drug against experimentally induced cryptosporidiosis in laboratory mice. Journal of Parasitic Diseases 47:2, pages 329-339.
Crossref
Crossref
A.F. Atia, N.M. Abou-Hussien, D.M. Sweed, E. Sweed & N.A. Abo-khalil. (2023)
Auranofin attenuates
Schistosoma mansoni
egg-induced liver granuloma and fibrosis in mice
. Journal of Helminthology 97.
Crossref
Crossref
Obaid Hayat, Nazif Ullah, Muhammad Sirajuddin, Miriam A. Giardini, Jennifer V. Nguyen, Karol R. Francisco, Lawrence J. Liu, Yujie Uli Sun, Svetlana Maurya, Dominic McGrosso, David J. Gonzalez, Conor R. Caffrey, Anjan Debnath & Jair L. Siqueira-Neto. (2022) A Broad Spectrum Antiparasitic Activity of Organotin (IV) Derivatives and Its Untargeted Proteomic Profiling Using Leishmania donovani. Pathogens 11:12, pages 1424.
Crossref
Crossref
Andrew J. Stevens, Rebecca Abraham, Kelly A. Young, Cecilia C. Russell, Siobhann N. McCluskey, Jennifer R. Baker, Bertha Rusdi, Stephen W. Page, Ryan O'Handley, Mark O'Dea, Sam Abraham & Adam McCluskey. (2022) Antigiardial Activity of Novel Guanidine Compounds. ChemMedChem 17:21.
Crossref
Crossref
Zhongwang Yu, Xue Fang, Weili Liu, Rui Sun, Jintao Zhou, Yingyan Pu, Ming Zhao, Dingya Sun, Zhenghua Xiang, Peng Liu, Yuqiang Ding, Li Cao & Cheng He. (2022) Microglia Regulate Blood–Brain Barrier Integrity via MiR‐126a‐5p/MMP9 Axis during Inflammatory Demyelination. Advanced Science 9:24, pages 2105442.
Crossref
Crossref
Helena Lucia Carneiro Santos & Karina M. Rebello. (2022) An Overview of Mucosa-Associated Protozoa: Challenges in Chemotherapy and Future Perspectives. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Katarzyna Dziduch, Dominika Greniuk & Monika Wujec. (2022) The Current Directions of Searching for Antiparasitic Drugs. Molecules 27:5, pages 1534.
Crossref
Crossref
Sajad Rashidi, Celia Fernández-Rubio, Reza Mansouri, Mohammad Ali-Hassanzadeh, Esmaeel Ghani, Mohammadreza Karimazar, Raúl Manzano-Román & Paul Nguewa. (2022) Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential. Parasitology Research 121:1, pages 49-62.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
535
592
.
Iman Fathy Abou-El-Naga & Nermine Mogahed Fawzy Hussein Mogahed. (2021) Repurposing auranofin for treatment of Experimental Cerebral Toxoplasmosis. Acta Parasitologica 66:3, pages 827-836.
Crossref
Crossref
Matthew A. Hulverson, Ryan Choi, Molly C. McCloskey, Grant R. Whitman, Kayode K. Ojo, Samantha A. Michaels, Mastanbabu Somepalli, Melissa S. Love, Case W. McNamara, Lesley M. Rabago, Lynn K. Barrett, Christophe L. M. J. Verlinde, Samuel L.M. Arnold, Boris Striepen, Dolores Jimenez-Alfaro, Lluis Ballell, Elena Fernández, M. Nicole Greenwood, Laura de las Heras, Felix Calderón & Wesley C. Van Voorhis. (2021)
Repurposing Infectious Disease Hits as Anti-
Cryptosporidium
Leads
. ACS Infectious Diseases 7:5, pages 1275-1282.
Crossref
Crossref
Donald J. AbrahamRoland E. Dolle, Laurel K. McGrane, James W. Janetka, Jared T. Hammill, Rodney Kiplin Guy, Anjan Debnath, Peter M. Cheuka, Claire Le Manach, Kelly Chibale, Ake Elhammer, Martin Handfield, Michael J. Dawson, Stefano Donadio, Jae H. Park & Alan Joslyn. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
95
.
LewisOscar Felix, Eleftherios Mylonakis & Beth Burgwyn Fuchs. (2021) Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive Bacteria. Frontiers in Microbiology 12.
Crossref
Crossref
Christopher I. Ma, James A. Tirtorahardjo, Sharon Jan, Sakura S. Schweizer, Shawn A. C. Rosario, Yanmiao Du, Jerry J. Zhang, Naomi S. Morrissette & Rosa M. Andrade. (2021) Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Debbie-Ann Shirley, Ishrya Sharma, Cirle A. Warren & Shannon Moonah. (2021) Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Isao Momose, Takefumi Onodera & Manabu Kawada. (2021) Potential Anticancer Activity of Auranofin金化合物Auranofinのがん微小環境特異的抗がん活性. YAKUGAKU ZASSHI 141:3, pages 315-321.
Crossref
Crossref
Valeria Scorza & Michael R. Lappin. 2021. Greene's Infectious Diseases of the Dog and Cat. Greene's Infectious Diseases of the Dog and Cat
1285
1300
.
Valeria Scorza & Michael R. Lappin. 2021. Greene's Infectious Diseases of the Dog and Cat. Greene's Infectious Diseases of the Dog and Cat
1263
1277
.
Yoalli Martínez-Pérez, Mario Nequiz-Avendaño, Itzhel García-Torres, Marco E. Gudiño-Zayas, Gabriel López-Velázquez, Sergio Enríquez-Flores, Edith Mendoza, Emma Saavedra, Ruy Pérez-Tamayo, Gloria León-Avila & Alfonso Olivos-García. (2020) Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence. Parasitology Research 119:10, pages 3491-3502.
Crossref
Crossref
Jose Ignacio Escrig, Hye Jee Hahn & Anjan Debnath. (2020)
Activity of Auranofin against Multiple Genotypes of
Naegleria fowleri
and Its Synergistic Effect with Amphotericin B
In Vitro
. ACS Chemical Neuroscience 11:16, pages 2464-2471.
Crossref
Crossref
Helena Lúcia Carneiro Santos, Karina Mastropasqua Rebello & Teresa Cristina Bergamo Bomfim. 2020. Parasitology and Microbiology Research. Parasitology and Microbiology Research.
Zahra Shahzadi, Ghulam Abbas & Syed Sikander Azam. (2020) Relational dynamics obtained through simulation studies of thioredoxin reductase: From a multi-drug resistant Entamoeba histolytica. Journal of Molecular Liquids 307, pages 112939.
Crossref
Crossref
Raúl Argüello-García, David Leitsch, Tina Skinner-Adams & M. Guadalupe Ortega-Pierres. 2020. Giardia and Giardiasis, Part B. Giardia and Giardiasis, Part B
201
282
.
I F Abou-El-Naga, M R Gaafar, M M Gomaa, S I Khedr & S N El Achy. (2019) Encephalitozoon intestinalis: A new target for auranofin in a mice model. Medical Mycology.
Crossref
Crossref
Monica M. Kangussu-Marcolino, Gretchen M. Ehrenkaufer, Emily Chen, Anjan Debnath & Upinder Singh. (2019) Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia. International Journal for Parasitology: Drugs and Drug Resistance 11, pages 80-94.
Crossref
Crossref
Fumika Mi-ichi, Takeshi Ishikawa, Vo Kha Tam, Sharmina Deloer, Shinjiro Hamano, Tsuyoshi Hamada & Hiroki Yoshida. (2019) Characterization of Entamoeba histolytica adenosine 5′-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis. PLOS Neglected Tropical Diseases 13:8, pages e0007633.
Crossref
Crossref
Harriet U Ugboko, Obinna C Nwinyi, Solomon U Oranusi, Toluwase H Fatoki, Paul A Akinduti & Jesupemi M Enibukun. (2019) In Silico Screening and Analysis of Broad-Spectrum Molecular Targets and Lead Compounds for Diarrhea Therapy. Bioinformatics and Biology Insights 13, pages 117793221988429.
Crossref
Crossref
Sumit Kumar, Trpta Bains, Ashley Sae Won Kim, Christina Tam, Jong Kim, Luisa W. Cheng, Kirkwood M. Land, Anjan Debnath & Vipan Kumar. (2018) Highly Potent 1H-1,2,3-Triazole-Tethered Isatin-Metronidazole Conjugates Against Anaerobic Foodborne, Waterborne, and Sexually-Transmitted Protozoal Parasites. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Crossref
Kelly M. Hennessey, Ilse C. Rogiers, Han-Wei Shih, Matthew A. Hulverson, Ryan Choi, Molly C. McCloskey, Grant R. Whitman, Lynn K. Barrett, Ethan A. Merritt, Alexander R. Paredez & Kayode K. Ojo. (2018) Screening of the Pathogen Box for inhibitors with dual efficacy against Giardia lamblia and Cryptosporidium parvum. PLOS Neglected Tropical Diseases 12:8, pages e0006673.
Crossref
Crossref
Joel H. Elizondo-Luévano, Rocío Castro-Ríos, Eduardo Sánchez-García, Magda E. Hernández-García, Javier Vargas-Villarreal, Osvelia E. Rodríguez-Luis & Abelardo Chávez-Montes. (2018)
In Vitro Study of Antiamoebic Activity of Methanol Extracts of
Argemone mexicana
on Trophozoites of
Entamoeba histolytica
HM1-IMSS
. Canadian Journal of Infectious Diseases and Medical Microbiology 2018, pages 1-8.
Crossref
Crossref
David Leitsch, Catrin F. Williams & Ivan Hrdý. (2018) Redox Pathways as Drug Targets in Microaerophilic Parasites. Trends in Parasitology 34:7, pages 576-589.
Crossref
Crossref
Fengguang Guo, Haili Zhang, Nina N McNair, Jan R Mead & Guan Zhu. (2018) The Existing Drug Vorinostat as a New Lead Against Cryptosporidiosis by Targeting the Parasite Histone Deacetylases. The Journal of Infectious Diseases 217:7, pages 1110-1117.
Crossref
Crossref
Joanna Nelson & Upinder Singh. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1310
1316.e2
.
Sylvia Afriyie Squire & Una Ryan. (2017) Cryptosporidium and Giardia in Africa: current and future challenges. Parasites & Vectors 10:1.
Crossref
Crossref
Edmund V. Capparelli, Robin Bricker-Ford, M. John Rogers, James H. McKerrow & Sharon L. Reed. (2017) Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent. Antimicrobial Agents and Chemotherapy 61:1.
Crossref
Crossref
Consuelo Gómez García, Laurence A. Marchat, Lilia López-Cánovas, D. Guillermo Pérez Ishiwara, Mario A. Rodríguez & Esther Orozco. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
613
628
.
U. Ryan, A. Zahedi & A. Paparini. (2016)
Cryptosporidium
in humans and animals—a one health approach to prophylaxis
. Parasite Immunology 38:9, pages 535-547.
Crossref
Crossref
Joshua P. Owings, Nina N. McNair, Yiu Fung Mui, Tomas N. Gustafsson, Arne Holmgren, Maria Contel, Joanna B. Goldberg & Jan R. Mead. (2016)
Auranofin and
N-
heterocyclic carbene gold-analogs are potent inhibitors of the bacteria
Helicobacter pylori
. FEMS Microbiology Letters 363:14, pages fnw148.
Crossref
Crossref
David A. Shoultz, Eugenio L. de Hostos & Robert K. M. Choy. (2016) Addressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality. PLOS Neglected Tropical Diseases 10:1, pages e0004242.
Crossref
Crossref
Arpita Saha, Amit Kumar Gaurav, Sudha Bhattacharya & Alok Bhattacharya. (2015) Molecular Basis of Pathogenesis in Amoebiasis. Current Clinical Microbiology Reports 2:4, pages 143-154.
Crossref
Crossref
Giuseppe Caramia, Stefania Silvi, Maria Cristina Verdenelli & Maria Magdalena Coman. (2015) Treatment of Acute Diarrhoea: Past and Now. International Journal of Enteric Pathogens 3:4.
Crossref
Crossref
Rosa M. Andrade & Sharon L. Reed. (2015) New drug target in protozoan parasites: the role of thioredoxin reductase. Frontiers in Microbiology 6.
Crossref
Crossref
Leire Aguinagalde, Roberto Díez-Martínez, Jose Yuste, Inmaculada Royo, Carmen Gil, Íñigo Lasa, Mar Martín-Fontecha, Nagore Isabel Marín-Ramos, Carmen Ardanuy, Josefina Liñares, Pedro García, Ernesto García & José M. Sánchez-Puelles. (2015)
Auranofin efficacy against MDR
Streptococcus pneumoniae
and
Staphylococcus aureus
infections
. Journal of Antimicrobial Chemotherapy 70:9, pages 2608-2617.
Crossref
Crossref
Hayley Sparks, Gayatri Nair, Alejandro Castellanos-Gonzalez & A. Clinton WhiteJr.Jr.. (2015) Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward. Current Tropical Medicine Reports 2:3, pages 181-187.
Crossref
Crossref
Una Ryan & Nawal Hijjawi. (2015) New developments in Cryptosporidium research. International Journal for Parasitology 45:6, pages 367-373.
Crossref
Crossref
Christine Roder & Melanie J. Thomson. (2015) Auranofin: Repurposing an Old Drug for a Golden New Age. Drugs in R&D 15:1, pages 13-20.
Crossref
Crossref
Christina A. Bulman, Chelsea M. Bidlow, Sara Lustigman, Fidelis Cho-Ngwa, David Williams, Alberto A. Rascón, Jr, Nancy Tricoche, Moses Samje, Aaron Bell, Brian Suzuki, K. C. Lim, Nonglak Supakorndej, Prasit Supakorndej, Alan R. Wolfe, Giselle M. Knudsen, Steven Chen, Chris Wilson, Kean-Hooi Ang, Michelle Arkin, Jiri Gut, Chris Franklin, Chris Marcellino, James H. McKerrow, Anjan Debnath & Judy A. Sakanari. (2015) Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis. PLOS Neglected Tropical Diseases 9:2, pages e0003534.
Crossref
Crossref
Graeme F. Wilkinson & Kevin Pritchard. (2015) In Vitro Screening for Drug Repositioning. SLAS Discovery 20:2, pages 167-179.
Crossref
Crossref
Anjan Debnath. 2015. Amebiasis. Amebiasis
553
564
.
Richard E. Kast, Georg Karpel-Massler & Marc-Eric Halatsch. (2014) CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 5:18, pages 8052-8082.
Crossref
Crossref